CELZ CREATIVE MEDICAL TECHNOLOGY...


$ -0.19 (-5.76 %)    

QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
$ 1.69 - $ 6.90
294,652
na
8.44M
$ -38.59
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 creative-medical-technology-launches-national-biodefense-inc-veterans-initiative-to-combat-burn-pit-exposure-using-ai-and-regenerative-cell-therapy

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) ("Creative Medical" or the "Company"), a clinical-stag...

 creative-medical-technologies-will-be-issued-us-patent-number-12391925-tomorrow-titled-prevention-andor-treatment-of-type-1-diabetes-by-augmentation-of-myeloid-suppressor-cell-activity

https://x.com/patentgrants/status/1957532080155562158?s=46&t=dtUiyC3dUs5yGRgT9qYHWg

 us-stocks-likely-to-open-lower-a-day-after-nasdaq-hits-record-high-nvidia-kellogg-klotho-in-focus

U.S. stock futures declined on Thursday after ending higher on Wednesday. Futures of major benchmark indices were trading lower.

 creative-medical-technology-has-received-a-notice-of-allowance-for-a-us-patent-titled-treatment-of-heart-failure-andor-post-infarct-pathological-remodeling-by-ex-vivo-reprogrammed-immune-cells

https://patentcenter.uspto.gov/applications/17559970/ifw/docs

 creative-medical-technology-announces-ovastem-shows-85-hormonal-improvement-70-success-orphan-drug-designation-filed

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a leading biotechnology innovator in regenerative medicine, enthusias...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION